Google alleges India antitrust entire body copied sections of EU get on Android abuse

Google alleges India antitrust entire body copied sections of EU get on Android abuse


Indian people communicate on their cell phones outside the Google stall at the India Cellular Congress in New Delhi on Sept. 27, 2017.

Prakash Singh | AFP | Getty Photos

Google has informed a tribunal in India that the country’s antitrust investigators copied pieces of a European ruling in opposition to the U.S. agency for abusing the current market dominance of its Android running method, arguing the conclusion be quashed, authorized papers clearly show.

The Levels of competition Commission of India (CCI) in October fined Alphabet Inc’s Google $161 million for exploiting its dominant position in markets such as on the internet search and the Android app retailer, and asked it to transform constraints imposed on smartphone makers related to pre-installing apps.

Sources advised Reuters in October that Google was nervous about the Indian decision as the remedies ordered were seen as more sweeping than the European Commission’s landmark 2018 ruling for imposing unlawful limits on Android cellular unit makers. Google has challenged a document 4.1-billion-euro ($4.3 billion) wonderful in that situation.

In its submitting to an Indian appeals tribunal, Google argues the CCI’s investigation unit “duplicate-pasted extensively from a European Fee conclusion, deploying proof from Europe that was not examined in India”.

“There are far more than 50 cases of copypasting”, in some conditions “phrase-for-phrase”, and the watchdog erroneously dismissed the concern, Google reported in its submitting which is not community but has been reviewed by Reuters.

“The Commission unsuccessful to conduct an impartial, well balanced, and lawfully sound investigation … Google’s cell app distribution methods are professional-competitive and not unfair/ exclusionary.”

Spokespeople for the CCI and European Commission did not promptly react to requests for remark.

Google explained in a assertion it made the decision to appeal the CCI’s conclusion as it thinks “it presents a big setback for our Indian people and corporations”. It did not comment on the duplicate-pasting allegations in its filing.

Google has asked the tribunal to quash the CCI’s purchase, and the situation will be read on Wednesday.

The Indian levels of competition ruling came as Google faces amplified antitrust scrutiny the planet over. Google licenses its Android procedure to smartphone makers, but critics say it imposes limits that are anti-aggressive.

The U.S. company states Android has designed additional option for absolutely everyone and these types of agreements assistance retain the running technique free. In Europe, 75% of 550 million smartphones operate on Android, as opposed with 97% of 600 million products in India, Counterpoint Research estimates.

The CCI ruled in Oct that Google’s licensing of its Enjoy Keep “shall not be joined with the need of pre-setting up” Google search products and services, the Chrome browser, YouTube or any other Google applications.

In its enchantment, Google alleges the CCI only located antitrust infringements connected to the Google search application, Chrome browser and YouTube, but its get “extends outside of” that.

Individually, Google has also appealed from another Indian antitrust final decision in which it was fined $113 million for limiting the use of 3rd-bash billing or payment processing expert services in India. The appeal is however to be read.



Supply

Trump half-billion-dollar civil fraud penalty thrown out by appeals court
World

Trump half-billion-dollar civil fraud penalty thrown out by appeals court

U.S. President Donald Trump stands next to Azerbaijan President Ilham Aliyev (not pictured) at the White House in Washington, D.C., U.S., August 8, 2025. Jessica Koscielniak | Reuters A New York state appeals court on Thursday threw out a more than $500 million civil business fraud penalty imposed on President Donald Trump. The appeals court […]

Read More
European pharma is spared worst-case U.S. tariffs. Investors still don’t trust the deal
World

European pharma is spared worst-case U.S. tariffs. Investors still don’t trust the deal

European pharmaceutical firms gained some much-desired clarity on Thursday, with news that U.S. tariffs will be capped at up to 15% — but a muted market reaction appeared to reflect skepticism among investors on whether the rate is set in stone. Fresh details on the European Union’s trade agreement with the White House revealed that […]

Read More
U.S. and EU spell out tariffs for autos, pharmaceuticals, and more
World

U.S. and EU spell out tariffs for autos, pharmaceuticals, and more

U.S. President Donald Trump shakes hands with President of the European Commission Ursula von der Leyen as he announces a trade deal with the EU at Trump Turnberry golf club on July 27, 2025 in Turnberry, Scotland. U.S. Andrew Harnik | Getty Images News | Getty Images The U.S. and European Union on Thursday revealed […]

Read More